Novartis needed its top leaders — commercial, medical, strategy — to stop optimising for their own function and start making decisions for the enterprise. A 3-day meeting had to do more than inspire: it had to change how people weigh trade-offs back at the desk.
The risk of these events is real talk gets replaced with polished talk. Leaders leave agreeing in principle and behaving the same in practice.